HK1212166A1 - Citrate rich calcium magnesium supplement and uses thereof - Google Patents
Citrate rich calcium magnesium supplement and uses thereofInfo
- Publication number
- HK1212166A1 HK1212166A1 HK16100422.0A HK16100422A HK1212166A1 HK 1212166 A1 HK1212166 A1 HK 1212166A1 HK 16100422 A HK16100422 A HK 16100422A HK 1212166 A1 HK1212166 A1 HK 1212166A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- calcium magnesium
- rich calcium
- magnesium supplement
- citrate
- citrate rich
- Prior art date
Links
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 title 1
- ZFXVRMSLJDYJCH-UHFFFAOYSA-N calcium magnesium Chemical compound [Mg].[Ca] ZFXVRMSLJDYJCH-UHFFFAOYSA-N 0.000 title 1
- 229940091250 magnesium supplement Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/40—Effervescence-generating compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1578—Calcium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/161—Magnesium
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Mycology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physiology (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261696662P | 2012-09-04 | 2012-09-04 | |
PCT/US2013/057927 WO2014039477A1 (fr) | 2012-09-04 | 2013-09-04 | Complément de calcium et de magnésium riche en citrate et ses utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1212166A1 true HK1212166A1 (en) | 2016-06-10 |
Family
ID=50237561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16100422.0A HK1212166A1 (en) | 2012-09-04 | 2016-01-14 | Citrate rich calcium magnesium supplement and uses thereof |
Country Status (9)
Country | Link |
---|---|
US (2) | US9539283B2 (fr) |
EP (2) | EP2892367B1 (fr) |
JP (2) | JP6348495B2 (fr) |
CN (1) | CN104703486A (fr) |
AU (2) | AU2013312884B2 (fr) |
CA (1) | CA2884062C (fr) |
ES (1) | ES2770830T3 (fr) |
HK (1) | HK1212166A1 (fr) |
WO (1) | WO2014039477A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3531841A1 (fr) | 2016-10-25 | 2019-09-04 | Third Wave Water LLC | Composition de traitement d'eau potable, et procédé de fabrication d'une composition de traitement d'eau potable |
EP3338772A1 (fr) | 2016-12-22 | 2018-06-27 | Merz Pharma GmbH & Co. KGaA | Compositions avec trimagnesiumdicittrate stabilise par acides hydroxycarboxyliques , leurs production et compositions concentrees de magnesium |
US20200078395A1 (en) * | 2018-09-07 | 2020-03-12 | The Board Of Regents Of The University Of Texas System | Averting complications of pump inhibitor therapy by effervescent calcium magnesium citrate |
CN115501201B (zh) * | 2022-09-16 | 2023-11-17 | 北京斯利安健康科技有限公司 | 复合钙镁维生素片及其制备方法 |
CN116530605A (zh) * | 2023-06-14 | 2023-08-04 | 威海百合生物技术股份有限公司 | 一种零食化钙镁果胶软糖及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62501843A (ja) * | 1985-02-19 | 1987-07-23 | ボ−ド・オブ・リ−ジェンツ・ザ・ユニバ−シティ−・オブ・テキサス・システム | 食事のカルシウム補足によるオステオポロ−シス抑制 |
US4814177A (en) * | 1986-03-18 | 1989-03-21 | Board Of Regents, University Of Texas System | Ultradense and more soluble and bioavailable preparations of calcium citrate |
US6616955B2 (en) * | 2001-01-04 | 2003-09-09 | The Proctor & Gamble Co. | Beverage compositions comprising palatable calcium and magnesium sources |
US7517868B2 (en) * | 2004-07-19 | 2009-04-14 | Ip-6 Research Inc | Phytic citrate compounds and process for preparing the same |
ITME20040015A1 (it) * | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
US20060223730A1 (en) | 2005-04-04 | 2006-10-05 | Hl Distribution Company | Calcium supplements |
CA2619591C (fr) * | 2005-08-18 | 2020-03-24 | Globoasia, Llc | Composes organiques ferriques, utilisations desdits composes et procedesde fabrication associes |
ES2699447T3 (es) * | 2006-01-30 | 2019-02-11 | Panion & Bf Biotech Inc | Citrato férrico para revertir, prevenir, retrasar o estabilizar la calcificación de tejidos blandos |
WO2008085728A2 (fr) * | 2007-01-06 | 2008-07-17 | Renjit Sundharadas | Combinaison médicamenteuse conçue pour traiter les effets d'un médicament utilisé pour réduire la sécrétion d'acide gastrique sur l'intégrité osseuse |
US8324191B2 (en) * | 2008-07-11 | 2012-12-04 | Biolink Life Sciences, Inc | Combined calcium, magnesium and vitamin D supplements |
-
2013
- 2013-09-04 EP EP13835639.9A patent/EP2892367B1/fr active Active
- 2013-09-04 WO PCT/US2013/057927 patent/WO2014039477A1/fr active Application Filing
- 2013-09-04 EP EP19216181.8A patent/EP3653061A1/fr not_active Withdrawn
- 2013-09-04 CN CN201380052390.0A patent/CN104703486A/zh active Pending
- 2013-09-04 AU AU2013312884A patent/AU2013312884B2/en active Active
- 2013-09-04 US US14/425,375 patent/US9539283B2/en active Active
- 2013-09-04 ES ES13835639T patent/ES2770830T3/es active Active
- 2013-09-04 CA CA2884062A patent/CA2884062C/fr active Active
- 2013-09-04 JP JP2015531155A patent/JP6348495B2/ja active Active
-
2016
- 2016-01-14 HK HK16100422.0A patent/HK1212166A1/xx unknown
- 2016-10-07 US US15/288,210 patent/US10092593B2/en active Active
-
2017
- 2017-05-09 AU AU2017203079A patent/AU2017203079B2/en active Active
-
2018
- 2018-05-31 JP JP2018104825A patent/JP2018150359A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2018150359A (ja) | 2018-09-27 |
WO2014039477A1 (fr) | 2014-03-13 |
ES2770830T3 (es) | 2020-07-03 |
AU2013312884B2 (en) | 2017-02-09 |
US9539283B2 (en) | 2017-01-10 |
US10092593B2 (en) | 2018-10-09 |
AU2017203079B2 (en) | 2018-03-08 |
CA2884062C (fr) | 2021-04-20 |
CA2884062A1 (fr) | 2014-03-13 |
EP2892367A4 (fr) | 2016-02-10 |
US20150224137A1 (en) | 2015-08-13 |
US20170020921A1 (en) | 2017-01-26 |
CN104703486A (zh) | 2015-06-10 |
AU2017203079A1 (en) | 2017-06-15 |
JP2015531345A (ja) | 2015-11-02 |
JP6348495B2 (ja) | 2018-06-27 |
AU2013312884A1 (en) | 2015-03-26 |
EP2892367B1 (fr) | 2019-12-18 |
EP2892367A1 (fr) | 2015-07-15 |
EP3653061A1 (fr) | 2020-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS2200034I1 (hu) | Glikokonjugációs eljárások és kompozíciók | |
HK1199023A1 (en) | Substituted benzothienylpyrrolotriazines and uses thereof | |
HK1200822A1 (en) | Substituted dipyridylamines and uses thereof | |
IL237309A0 (en) | Benzocyclooctyne compounds and uses thereof | |
EP2852952A4 (fr) | Audition de contenu audio | |
HK1213455A1 (zh) | 醫療用緊固件 | |
BR112014032049A2 (pt) | citrato férrico e suplemento de ferro oral | |
HK1210949A1 (en) | Combinations and uses thereof | |
ZA201501172B (en) | AQUEOUS FOOD COMPOSITION ENRICHED IN ß-GLUCAN | |
EP2867209A4 (fr) | Composés et leurs utilisations thérapeutiques | |
EP2875014A4 (fr) | Médicaments anti-mucus et leurs utilisations | |
EP2822405A4 (fr) | Complément alimentaire | |
GB201204430D0 (en) | Dietary supplement and assay method | |
EP2822404A4 (fr) | Complément alimentaire | |
HK1212166A1 (en) | Citrate rich calcium magnesium supplement and uses thereof | |
EP2895179A4 (fr) | Fer contenant un complément nutritionnel | |
HK1210809A1 (en) | Beta-hexosyl-transferases and uses thereof | |
HK1205001A1 (en) | Nutritional composition | |
EP2925335A4 (fr) | Supplément de santé gastrique et procédés correspondants | |
HK1212164A1 (en) | Beta-hydroxy-beta-methylbutryic acid- containing compositions and uses thereof --- | |
SG11201505131UA (en) | Sphingomyelin-containing supplement | |
HUE032878T2 (hu) | Bõrvédõ és bõrkiegyensúlyozó készítmény | |
GB201308011D0 (en) | Calcium supplement | |
GB201222342D0 (en) | Compounds and uses thereof |